A Prospective, Randomized, Parallel Crossover Study Demonstrating Subject Wearability and Usability of the I-Port Injection Port

NACompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

October 31, 2006

Study Completion Date

January 31, 2007

Conditions
Type 1 DiabetesType 2 Diabetes
Interventions
DEVICE

I-Port(TM) Injection Port

Trial Locations (5)

30309

Atlanta Diabetes Associates, Atlanta

68131

Diabetes and Endocrine Associates, Omaha

75231

Research Institute of Dallas, Dallas

78729

Diabetes and Glandular Disease Clinic, San Antonio

78731

Texas Diabetes & Endocrinology, Austin

Sponsors
All Listed Sponsors
collaborator

Medstar Health Research Institute

OTHER

collaborator

Valeritas, Inc.

INDUSTRY

lead

Patton Medical Devices

INDUSTRY